Back
Lucid Group Vs. Kymera Therapeutics Industry Stock Comparison
Sell
23
LCID
Lucid Group
Last Price:
3.25
Seasonality Move:
4.5%
Buy
67
KYMR
Kymera Therapeutics
Last Price:
46.52
Seasonality Move:
1.07%
Sell
23
Lucid Group (LCID)
is a Sell
Is Lucid Group a Buy, Sell or Hold?
- The current Lucid Group [LCID] share price is $3.25. The Score for LCID is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- LCID is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $44.55. The Score for KYMR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LCID Stock Price Chart
What is Lucid Group's stock price today?
-
The Lucid Group share price today is $3.25
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LCID is experiencing buying pressure, which is a positive indicator for future bullish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $44.55
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight buying pressure.
LCID Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 51.89 | Buy |
| Chaikin Money Flow: | 17324614 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.06 - 3.58) | Sell |
| Bollinger Bands (100): | (2.52 - 3.26) | Buy |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.14 | Buy |
| Relative Strength Index (14 RSI): | 58.42 | Buy |
| Chaikin Money Flow: | 103123 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.47 - 45.27) | Buy |
| Bollinger Bands (100): | (32.4 - 41.62) | Buy |
LCID Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.13 | Buy |
| 20-day SMA: | 3.23 | Buy |
| 50-day SMA: | 3.08 | Buy |
| 200-day SMA: | 3.28 | Sell |
| 8-day EMA: | 3.16 | Buy |
| 20-day EMA: | 3.19 | Buy |
| 50-day EMA: | 3.12 | Buy |
| 200-day EMA: | 3.72 | Sell |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43 | Buy |
| 20-day SMA: | 42.98 | Buy |
| 50-day SMA: | 38.46 | Buy |
| 200-day SMA: | 33.24 | Buy |
| 8-day EMA: | 43.29 | Buy |
| 20-day EMA: | 42.42 | Buy |
| 50-day EMA: | 40 | Buy |
| 200-day EMA: | 34.31 | Buy |
Lucid Group Earnings Growth & LCID Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.03 per share, an increase this year of $0.23 per share, and an increase next year of $0.22 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.38 per share.
Lucid Group Technical Analysis
| Aug 6 | Aug 7 | Aug 8 | Aug 9 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 16 | Aug 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics Technical Analysis
| Aug 6 | Aug 7 | Aug 8 | Aug 9 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 16 | Aug 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||